Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
DEMECAN One
- Development stage
- Unknown
- Lead developer
- DEMECAN
- Modality
- Small Molecules
- Administration
- Inhalation, Oral, Sublingual
01
Overview
DEMECAN One is a line of medical cannabis extracts and concentrates developed and manufactured by the German pharmaceutical company DEMECAN. Derived from the Indica-dominant Bubba Kush cultivar grown domestically in Germany under GMP conditions, DEMECAN One products include solvent-free CO2 extracts (such as DEMECAN One concentrate 850) and fresh extracts produced via a solventless live rosin process (such as DEMECAN FE 800 No. 1). These products are highly concentrated in tetrahydrocannabinol (THC) and are prescribed in Germany for the treatment of chronic pain, sleep disorders, anxiety, and depression. THC acts primarily as a partial agonist of the cannabinoid CB1 and CB2 receptors, providing analgesic, muscle-relaxant, and sedating therapeutic effects.
- Brand names
- DEMECAN FE 800 No. 1DEMECAN Oktonia Typ1DEMECAN OneDEMECAN One concentrate 850
- Other names
- Bubba Kush (DEMECAN)DEMECAN ONE
02
Targets
CNR1 (Cannabinoid receptor 1)
Beyond the preview
Go deeper on DEMECAN One.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on DEMECAN One.